Payment will be shared by 48 states and the District of Columbia
MONDAY, Sept. 28, 2020 (HealthDay News) — A company has agreed to pay $60 million to settle charges by U.S. state attorneys general that it failed to adequately inform women of dangerous side effects associated with permanent pelvic mesh devices.
The payment by C.R. Bard Inc. and its parent company Becton, Dickinson and Co. will be shared by 48 states and the District of Columbia, CBS News reported.
“Bard failed to disclose serious and life-altering risks of permanently implanted surgical mesh devices, leaving thousands of women to suffer,” Mississippi Attorney General Lynn Fitch said in a statement. “This settlement holds Bard accountable for its deceptive business practices.”
C.R. Bard and its parent company have denied any allegations of wrongdoing, and chose to settle the matter “to avoid the time and expense of further litigation,” according to Troy Kirkpatrick, a spokesperson for Becton, Dickinson and Co., CBS News reported.
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement 
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction 
Early Complications Common in Older Kidney Transplant Recipients 
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 
Frequent Cannabis Use Linked to Epilepsy Severity 
Less Intraoperative Crystalloid Fluid Not Tied to Worse Surgical Outcomes 
.jpg)
